Immunoglobulins, Intravenous: all 232 studies that test it
Page 3 of 3. Open to participants first (31), then studies with results posted, then the rest; newest registration first within each.
- Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic PainStatus unknownNCT00850005Phase 2
- Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids.CompletedNCT00809822Phase 2
- Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV SubcutaneouslyCompletedNCT00782106Phase 1/2
- Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent MiscarriageCompletedNCT00722475Phase 3
- IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral LoadStatus unknownNCT00659386Phase 1
- Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal TransplantationCompletedNCT00642655Phase 1/2
- Intravenous Immunoglobulins as Effective Treatment in Sydenham's ChoreaCompletedNCT00615797Not applicable
- Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen EncephalitisStatus unknownNCT00545493Phase 2/3
- Treatment of Deficient Subclass or Anti-polysaccharide Antibody ResponseCompletedNCT00522821Phase 4
- Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia GravisCompletedNCT00515450Phase 3
- Intravenous Immunoglobulin in Combination Therapy With Antibacterial Agents for SSI of the Lower Digestive TractWithdrawnNCT00511212Not applicable
- Preventive IVIG Therapy for Congenital Heart BlockCompletedNCT00460928Early Phase 1
- Effect of Intravenous Immunglobulin (IVIG) After Myocardial InfarctionCompletedNCT00430885Phase 3
- Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent InfectionsCompletedNCT00417573Phase 2
- A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.CompletedNCT00376077Phase 3
- Efficacy and Safety Study of GB-0998 for Treatment of Systemic SclerosisCompletedNCT00348296Phase 3
- Intravenous Immunoglobulin After Relapse in VasculitisTerminatedNCT00307658Phase 3
- IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and MelanomaStatus unknownNCT00294476Phase 2
- Subcutaneous Immunoglobulin Treatment for Multifocal Motor NeuropathyCompletedNCT00268788Phase 2
- Post-Poliosyndrome Treated With Intravenous Immunoglobulin (IvIg)CompletedNCT00231439Phase 2/3
- Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency PatientsCompletedNCT00220766Phase 3
- Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant RecipientsCompletedNCT00176059Early Phase 1
- Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic PurpuraCompletedNCT00162006Phase 2
- Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)CompletedNCT00161993Phase 2
- Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersCompletedNCT00157079Phase 3
- Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%TerminatedNCT00090194Phase 2
- High-Dose Intravenous Immunoglobulin to Treat Cerebellar DegenerationCompletedNCT00034242Phase 2
- Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)CompletedNCT00001768Phase 3
- Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)CompletedNCT00001550Phase 1
- Intravenous Immunoglobulin (IVIg) for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CompletedNCT00001287Phase 2
- An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant AntigensCompletedNCT00000935Phase 3
- Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune GlobulinCompletedNCT00000580Phase 3